Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Blood (2023) 142 (Supplement 1): 4328.

https://doi.org/10.1182/blood-2023-180291

Published: 2023

Journal Articles

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD, Tomoko Hata, Toshihiro Miyamoto, MD PhD, Hiroshi Kawabata, MD PhD, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, PhD, Itaru Matsumura, MDPhD, Seishi Ogawa, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD, Kinuko Mitani

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134483

Published: 2020

Journal Articles

Characterization of Pathogenic Variants and Clinical Phenotypes in 117 Japanese Fanconi Anemia Patients

Minako Mori, MD, Asuka Hira, MD PhD, Kenichi Yoshida, MD PhD, Hideki Muramatsu, MD PhD, Yusuke Okuno, MD PhD, Michiko Anmae, MS, Kazuo Tamura, MD PhD, Jun Yasuda, MD PhD, Tomoo Osumi, MD, Yasushi Noguchi, MD, Souichi Adachi, MD PhD, Hiroshi Kawabata, MD PhD, Akifumi Takaori-Kondo, MD PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Hiromasa Yabe, MD, PhD, Miharu Yabe, MD PhD, Minoru Takata, MD PhD

Blood (2018) 132 (Supplement 1): 3860.

https://doi.org/10.1182/blood-2018-99-110362

Published: 2018

Journal Articles

Generation of Patient-Derived Human Induced Pluripotent Stem Cells in X-Linked Sideroblastic Anemia and Novel Therapeutic Strategies

Yuki Morimoto, MD, Kazuhisa Chonabayashi, MD PhD, Masayuki Umeda, MD, Hiroshi Kawabata, MD PhD, Akifumi Takaori-Kondo, MD PhD, Yoshinori Yoshida, MD PhD

Blood (2017) 130 (Supplement 1): 938.

https://doi.org/10.1182/blood.V130.Suppl_1.938.938

Published: 2017

Journal Articles

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

Hiroshi Kawabata, MD PhD, Kaoru Tohyama, MD PhD, Akira Matsuda, MD PhD, Kayano Araseki, MD PhD, Tomoko Hata, MD PhD, Takahiro Suzuki, MD, PhD, Hidekazu Kayano, MD PhD, Kei Shinbo, MT, Kensuke Usuki, MD PhD, Akira Hangaishi, MD PhD, Shigeru Chiba, MD, PhD, Nogawa Masaharu, MD PhD, Nobuyoshi Arima, MD PhD, Takayuki Ishikawa, MD PhD, Keiya Ozawa, MD PhD, Shunya Arai, MD, PhD, Mineo Kurokawa, MD, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 5530.

https://doi.org/10.1182/blood.V128.22.5530.5530

Published: 2016

Journal Articles

Comparison of Laboratory Data of Patients with Tafro Syndrome and Idiopathic Multicentric Castleman Disease: A Japanese Retrospective Study

Shino Fujimoto, MD, Hiroshi Kawabata, MD PhD, Nozomu Kurose, MD PhD, Kazue Takai, MD PhD, Masaru Kojima, MD PhD, Norifumi Tsukamoto, MD PhD, Tomohiro Kinoshita, MD PhD, Shigeo Nakamura, MD PhD, Sadao Aoki, MD PhD, Yasufumi Masaki, MD PhD

Blood (2016) 128 (22): 4893.

https://doi.org/10.1182/blood.V128.22.4893.4893

Published: 2016

Journal Articles

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

June Takeda, MD, Hiroshi Kawabata, MD, PhD, Kazunari Aoki, MD, Shuichi Shiga, S.H., Masahiro Kawahara, MD PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiyuki Kitano, MD, Noboru Yonetani, MD, Sumie Tabata, MD, PhD, Nobuhiro Hiramoto, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, Norimitsu Kadowaki, MD PhD, Akifumi Takaori, MD, PhD

Blood (2014) 124 (21): 1907.

https://doi.org/10.1182/blood.V124.21.1907.1907

Published: 2014

Journal Articles

Suppressing Hepcidin By Tocilizumab Effectively Improve Anemia in Inflammatory Diseases: Clinical Evidence and Basic Mechanisms

Kazuyuki Yoshizaki, Soken-Nakazawa J Song, Hiroshi Kawabata

Blood (2014) 124 (21): 4006.

https://doi.org/10.1182/blood.V124.21.4006.4006

Published: 2014

Journal Articles

Analysis Of The Molecular Mechanisms Leading To Significantly Higher Serum Hepcidin and More Severe Anemia In Multicentric Castleman’s Disease (MCD) Patients Than In Rheumatoid Arthritis (RA) Patients

Soken-Nakazawa J. Song, MD, PhD, Hiroshi Kawabata, MD, PhD, Kazuyuki Yoshizaki, MD, PhD

Blood (2013) 122 (21): 2181.

https://doi.org/10.1182/blood.V122.21.2181.2181

Published: 2013

Journal Articles

Serum Neutrophil Extracellular Traps (NETs) Are a Potential Predictive Marker for Thrombotic Microangiopathy (TMA) After Allogeneic Stem Cell Transplantation

Yasuyuki Arai, MD, Soichiro Sakamoto, MD, Kouhei Yamashita, MD, PhD, Kiyomi Mizugishi, MD, PhD, Toshiyuki Kitano, MD, Tadakazu Kondo, MD, PhD, Hiroshi Kawabata, MD, PhD, Norimitsu Kadowaki, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2012) 120 (21): 1919.

https://doi.org/10.1182/blood.V120.21.1919.1919

Published: 2012

Journal Articles

Impact of Serum Ferritin Levels on the Incidence of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Soichiro Sakamoto, MD, Hiroshi Kawabata, MD, PhD, Junya Kanda, MD, PhD, Tatsuki Uchiyama, MD, Chisaki Mizumoto, MD, Tadakazu Kondo, MD, PhD, Tatsuo Ichinohe, MD, PhD, Takayuki Ishikawa, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2010) 116 (21): 1248.

https://doi.org/10.1182/blood.V116.21.1248.1248

Published: 2010

Journal Articles

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata, Takayuki Ishikawa, Teppei Nishikawa, Kazuyuki Yoshizaki

Blood (2010) 116 (18): 3627–3634.

https://doi.org/10.1182/blood-2010-03-271791

Published: 2010

Includes: Supplemental data

Journal Articles

Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation

Junya Kanda, Chisaki Mizumoto, Hiroshi Kawabata, Tatsuo Ichinohe, Hideyuki Tsuchida, Naohisa Tomosugi, Keitaro Matsuo, Tadakazu Kondo, Takayuki Ishikawa, MD, PhD, Takashi Uchiyama

Blood (2008) 112 (11): 1160.

https://doi.org/10.1182/blood.V112.11.1160.1160

Published: 2008

Journal Articles

Monitoring of Serum Hepcidin-25 in Multicentric Castleman’s Disease Patients Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody.

Hiroshi Kawabata, MD, Naohisa Tomosugi, MD, Junya Kanda, MD, Chisaki Mizumoto, MD, Yasuhiro Tanaka, MD, Tatsuo Ichinohe, MD, Norimitsu Kadowaki, MD, Kazuyuki Yoshizaki, MD, Takayuki Ishikawa, MD, Takashi Uchiyama, MD

Blood (2007) 110 (11): 3686.

https://doi.org/10.1182/blood.V110.11.3686.3686

Published: 2007

Journal Articles

Serum Level of Hepcidin and Erythropoietic Activity after Hematopoietic Stem Cell Transplantation.

Junya Kanda, MD, Chisaki Mizumoto, M.D., Hiroshi Kawabata, M.D., Hideyuki Tsuchida, M.D., Naohisa Tomosugi, M.D., Takashi Uchiyama, M.D.

Blood (2007) 110 (11): 3000.

https://doi.org/10.1182/blood.V110.11.3000.3000

Published: 2007

Journal Articles

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

Naohisa Tomosugi, Hiroshi Kawabata, Rumi Wakatabe, Masato Higuchi, Hideki Yamaya, Hisanori Umehara, Isao Ishikawa

Blood (2006) 108 (4): 1381–1387.

https://doi.org/10.1182/blood-2005-10-4043

Published: 2006

Includes: Supplemental data

Journal Articles

Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis

Hiroshi Kawabata, Robert E. Fleming, Dorina Gui, Seo Y. Moon, Takayuki Saitoh, James O'Kelly, Yutaka Umehara, Yuji Wano, Jonathan W. Said, H. Phillip Koeffler

Blood (2005) 105 (1): 376–381.

https://doi.org/10.1182/blood-2004-04-1416

Published: 2005

Journal Articles

Analysis of Lymphocyte Monoclonality in Patients with Sjögren’s Syndrome Associated with Lymphoproliferative Disorder or Lymphoma.

Yasufumi Masaki, MD, Lingli Dong, MD, Hiroshi Kawabata, MD, Yuko Hirose, MD, Susumu Sugai, MD

Blood (2004) 104 (11): 4547.

https://doi.org/10.1182/blood.V104.11.4547.4547

Published: 2004

Journal Articles

Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells

Hiroshi Kawabata, Tsuyoshi Nakamaki, Pranvera Ikonomi, Reginald D. Smith, Rasha S. Germain, H. Phillip Koeffler

Blood (2001) 98 (9): 2714–2719.

https://doi.org/10.1182/blood.V98.9.2714

Published: 2001

Journal Articles

Regulation of expression of murine transferrin receptor 2

Hiroshi Kawabata, Rasha S. Germain, Takayuki Ikezoe, Xiangjun Tong, Eric M. Green, Adrian F. Gombart, H. Phillip Koeffler

Blood (2001) 98 (6): 1949–1954.

https://doi.org/10.1182/blood.V98.6.1949

Published: 2001

NARROW

Prognostic Impact of Chromosomal Abnormalities in TP53 -Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Characterization of Pathogenic Variants and Clinical Phenotypes in 117 Japanese Fanconi Anemia Patients

Generation of Patient-Derived Human Induced Pluripotent Stem Cells in X-Linked Sideroblastic Anemia and Novel Therapeutic Strategies

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

Comparison of Laboratory Data of Patients with Tafro Syndrome and Idiopathic Multicentric Castleman Disease: A Japanese Retrospective Study

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

Suppressing Hepcidin By Tocilizumab Effectively Improve Anemia in Inflammatory Diseases: Clinical Evidence and Basic Mechanisms

Analysis Of The Molecular Mechanisms Leading To Significantly Higher Serum Hepcidin and More Severe Anemia In Multicentric Castleman’s Disease (MCD) Patients Than In Rheumatoid Arthritis (RA) Patients

Serum Neutrophil Extracellular Traps (NETs) Are a Potential Predictive Marker for Thrombotic Microangiopathy (TMA) After Allogeneic Stem Cell Transplantation

Impact of Serum Ferritin Levels on the Incidence of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation

Monitoring of Serum Hepcidin-25 in Multicentric Castleman’s Disease Patients Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody.

Serum Level of Hepcidin and Erythropoietic Activity after Hematopoietic Stem Cell Transplantation.

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis

Analysis of Lymphocyte Monoclonality in Patients with Sjögren’s Syndrome Associated with Lymphoproliferative Disorder or Lymphoma.

Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells

Regulation of expression of murine transferrin receptor 2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only